Exhibit 99.1 Bioventus Reports Third Quarter Financial Results • Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* Growth • Q3 Gross Margin Expanded 200 bps • Q3 Cash from Operations of $10.3 million, an Increase of $18.6 million Compared to Previous Year DURHAM, NC – November 5, 2024 – Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 28, ...